Search Results 1351-1360 of 13927 for Assay

  1. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. Colorectal Cancer Screening/Microbiome ...

  2. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    Patients with disease measurable by serum light chain assay alone are eligible (defined as ≥ 100 mg/L on involved light chain). Patients must not have any ...

  3. Shanafelt Archives - Mayo Clinic News Network

    ... assays about eight years ago, and it was found to reduce the survival of CLL leukemic cells. This laboratory finding was followed by a successful phase I ...

  4. A Blood Collection Protocol To Study The Immune Responses Of Cancer Patients With Malignancies - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  5. Randomized, Open Label, Clinical Study Of The Targeted Therapy, Palbociclib, To Treat Metastatic Breast Cancer

    ... assays, compared with DCIS-like lesions developing from RB-proficient cells. Conversely, the invasive phenotype observed in ErbB2-positive cancer models was ...

  6. Hematology - Clinical trials

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  7. Stage 4 Prostate Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to correlate the parathyroid hormone-related peptide (PTHrp) levels in the current and new assays in patients with known disease ...

  8. Cancer Treatment Clinical Trials - Mayo Clinic Research

    ... assays and devices for early detection of colorectal neoplasia. A Study Of RLY-4008 In Patients With Intrahepatic Cholangiocarcinoma And Other Advanced ...

  9. ADJUSTING SIGNIFICANCE LMELS IN CENSORED DATA WHEN USING MULTIPLE TESTS SIMULTANEOUSLY by THOMAS R. FLE!YING and DAVID P. YARRIN

    I. Introduction. The last thirty years have seen a considerable increase in the amount of research literature in statistics.

  10. Clinical trials - Oncology (Medical)

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...